首页> 外文OA文献 >Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells

【2h】

Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells

机译：结合受体酪氨酸激酶抑制剂AEE788和雷帕霉素（mTOR）抑制剂RAD001的哺乳动物靶点可强烈抑制肾癌细胞的粘附和生长

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jüngel Eva; Engler Johanna; Natsheh Iyad; Jones Jon; Mickuckyte Ausra; Hudak Lukasz; Jonas Dietger; Blaheta Roman A.;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells [J] . Eva Juengel, Johanna Engler, Iyad Natsheh, BMC Cancer . 2009,第1期

机译：结合受体酪氨酸激酶抑制剂AEE788和雷帕霉素（mTOR）抑制剂RAD001的哺乳动物靶点可强烈抑制肾癌细胞的粘附和生长
2. Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells [J] . Eva Juengel, Johanna Engler, Iyad Natsheh, BMC Cancer . 2009,第1期

机译：结合受体酪氨酸激酶抑制剂AEE788和雷帕霉素（mTOR）抑制剂RAD001的哺乳动物靶点可强烈抑制肾癌细胞的粘附和生长
3. Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI. [J] . Kwonoh Park, Jae-Lyun Lee, Inkeun Park, Medical oncology . 2012,第5期

机译：一线VEGF TKI失败后，转移性肾细胞癌患者中血管内皮生长因子（VEGF）酪氨酸激酶抑制剂（TKI）和哺乳动物靶雷帕霉素（mTOR）抑制剂作为二线治疗的比较疗效。
4. The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses Proliferation and Invasion of Human Oral Squamous Carcinoma Cells via p53 Independent and MMP, uPAR Dependent Mechanism [C] . EUN JU LEE, JIN HA WHANG, NAM KYEONG JEON, Meeting on Cell Signaling World: Signal Transduction Pathways as Therapeutic Targets . 2007

机译：表皮生长因子受体酪氨酸激酶抑制剂ZD1839（Iressa）通过独立于p53和MMP，uPAR依赖性机制抑制人口腔鳞状细胞癌细胞的增殖和侵袭
5. The multi-targeted receptor tyrosine kinase inhibitor, linifanib (ABT-869), induces apoptosis and inhibits proliferation of leukemia cells through phosphoinositide-3 kinase (PI3K)/AKT-dependent signaling pathways. [D] . Hernandez, Jenny Elizabeth. 2010

机译：多靶点受体酪氨酸激酶抑制剂利尼法尼（ABT-869）通过磷酸肌醇3激酶（PI3K）/ AKT依赖性信号传导途径诱导凋亡并抑制白血病细胞的增殖。
6. Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells [O] . Eva Juengel, Johanna Engler, Iyad Natsheh, 2009

机译：结合受体酪氨酸激酶抑制剂AEE788和雷帕霉素（mTOR）抑制剂RAD001的哺乳动物靶点可强烈抑制肾癌细胞的粘附和生长
7. Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells [O] . Eva Juengel, Johanna Engler, Iyad Natsheh, 2009

机译：结合受体酪氨酸激酶抑制剂AEE788和雷帕霉素（mTOR）抑制剂RAD001的哺乳动物靶点可强烈抑制肾癌细胞的粘附和生长

Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells

著录项

相似文献

相关主题

期刊订阅